Effect of intravenous Vitamin B6 administration in chemotherapy induced nausea and vomiting

Evaluation of intravenous Vitamin B6 administration in chemotherapy induced nausea and vomiting in children suffering from malignancy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N67

Enrollment

100

Registered

2018-02-16

Start date

2017-03-10

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy in children. Extravasation of vesicant antineoplastic chemotherapy

Interventions

Intervention group: In intervention group, patients are provided by Granisteron, 3 milligram in 3 milliliter, intravenously, 30 minutes before chemotherapy and vitamin B6 100 mg in 2-5 year age group,

Eligibility

Sex/Gender

All

Age

2 Years to 5 Years

Inclusion criteria

Inclusion criteria: being at the age of 2 to 5 years both gender Children with malignancy

Exclusion criteria

Exclusion criteria: Dissatisfaction to participate in the study

Design outcomes

Primary

Measure	Time frame
Nausa. Timepoint: From beginning to the end of the chemotherapy session. Method of measurement: questionnaire.;Vomitting. Timepoint: From beginning to the end of the chemotherapy session. Method of measurement: questionnaire.;Severity of nausea and vomiting. Timepoint: From beginning to the end of the chemotherapy session. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Aziz Eghbali

Arak University of Medical Sciences

Eghbali@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026